# CABERGOLINE

NDC: 70069-824
Generic name: CABERGOLINE
Labeler / Manufacturer: Somerset Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20241018

FDA application: ANDA218109

## Active ingredients

- CABERGOLINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-824"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-824
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0fb5556-de2c-4822-9960-0700e2907890